Dr. Robert F. Tassan, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Robert F. Tassan, who serves patients throughout the State of New Jersey.

A highly trained hematologist-oncologist, Dr. Tassan has been treating patients in Bergen County for more than 8 years. He is currently affiliated with Regional Cancer Care Associates, seeing patients at their offices in Franklin Lakes and Westwood, New Jersey.

With over 20 locations throughout New Jersey, Connecticut, Maryland, and the Washington, DC area, the cancer and blood disorder specialists at Regional Cancer Care Associates offer world-class care close to home, so that patients can focus on the most important thing in the world – their health.

Pertaining to his educational pursuits, Dr. Tassan graduated with his medical degree from the UMDNJ Robert Wood Johnson Medical School. He then went on to further his training by completing a residency in internal medicine and a fellowship in hematology/medical oncology at the UMDNJ Robert Wood Johnson University Hospital. He also holds a Bachelor of Science degree from Manhattan College.

As a testament of his continued education, the doctor is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In his professional experience, he has admitting privileges at HMH Hackensack University Medical Center and Pascack Valley Medical Center, and serves as an associate of the Advisory Board for Physician Leadership Development at The Valley Hospital.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Among his most notable achievements, Dr. Tassan has been the recipient of the Melvyn H. Motolinsky Outstanding Fellow Award.

Recommended Articles

• Exercise Proven to Help Lymphoma Patients

  People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research

  There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...

• AstraZeneca Gains United States Approval for Lymphoma Drug

  Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...